HIF1A and metabolic dysfunction-associated steatotic liver disease: A comprehensive understanding of the mechanisms underlying cholesterol-triggered NAFLD progression, including the involvement of HIF1A and its effects on microcirculation and inflammation, may have important implications in developing therapies targeting this condition (Figure 9).